Hydrocortisone Butyrate Cream

Ülke: Yeni Zelanda

Dil: İngilizce

Kaynak: Medsafe (Medicines Safety Authority)

Aktif bileşen:

Hydrocortisone butyrate 0.1%{relative}

Mevcut itibaren:

AFT Pharmaceuticals Ltd

INN (International Adı):

Hydrocortisone butyrate 0.1% w/w

Doz:

0.1 %

Farmasötik formu:

Topical cream

Kompozisyon:

Active: Hydrocortisone butyrate 0.1%{relative} Excipient: Butyl hydroxybenzoate Cetomacrogol 1000 Cetostearyl alcohol Citric acid Light liquid paraffin Propyl hydroxybenzoate Purified water Sodium citrate White soft paraffin

Paketteki üniteler:

Tube, laminate with polypropylane cap, 10 g

Sınıf:

Prescription

Reçete türü:

Prescription

Tarafından üretildi:

Taro Pharmaceutical Industries Ltd

Ürün özeti:

Package - Contents - Shelf Life: Tube, laminate with polypropylane cap - 10 g - 24 months from date of manufacture stored at or below 25°C - Tube, laminate with polypropylane cap - 30 g - 24 months from date of manufacture stored at or below 25°C - Tube, aluminium, internally lacquered with HDPE cap - 15 g - 24 months from date of manufacture stored at or below 25°C - Tube, aluminium, internally lacquered with HDPE cap - 45 g - 24 months from date of manufacture stored at or below 25°C

Yetkilendirme tarihi:

2008-06-09

Ürün özellikleri

HYDROCORTISONE BUTYRATE 
_HYDROCORTISONE 17-BUTYRATE 0.1% W/W TOPICAL CREAM _
_HYDROCORTISONE 17-BUTYRATE 0.1% W/W TOPICAL OINTMENT _

PRESENTATION 
A smooth white cream containing 0.1% w/w hydrocortisone butyrate. 
An ointment containing 0.1% w/w hydrocortisone butyrate in a polyethylene and 
mineral oil base. 

USES 
_ACTIONS _
Hydrocortisone 17-butyrate is a synthetic corticosteroid with anti-inflammatory, anti-
eczematous, anti-allergic and anti-pruritic properties and is indicated in the topical 
treatment of a variety of acute and chronic skin disorders. Therapeutically effective 
concentrations of the corticosteroid are obtained in the skin tissues by percutaneous 
absorption or penetration resulting in a rapid anti-inflammatory and anti-pruritic effect. 
Hydrocortisone Butyrate Cream is therefore suitable for the treatment of eczemas 
and dermatitis characterized by primary or secondary efflorescences which have 
been found to respond to corticosteroid treatment, e.g. psoriasis, lichen simplex. 
_PHARMACOKINETICS _
Percutaneous penetration of corticosteriods varies between patients and can be 
increased by the use of occlusive dressings, increasing the concentration of the 
corticosteroid or by using different vehicles. 
Once absorbed through the skin, topical corticosteroids follow pharmacokinetic 
pathways similar to systemically administered corticosteroids. Hydrocortisone 17-
butyrate is metabolised primarily by the liver to hydrocortisone and other metabolites. 
These and traces of the unmetabolised hydrocortisone butyrate are excreted via the 
urine or bile. 
_INDICATIONS _
Treatment of conditions responsive to topical corticosteroids e.g. eczema, dermatitis 
and psoriasis. 

DOSAGE AND ADMINISTRATION 
ADULTS AND CHILDREN 
Apply to the affected areas 1 to 4 times daily o